Curcumin in chronic lymphocytic leukemia – A review | Zendy

Vagish Kumar L Shanbhag | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Curcumin in chronic lymphocytic leukemia – A review

Author(s) -

Vagish Kumar L Shanbhag

Publication year - 2017

Publication title -

asian pacific journal of tropical biomedicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.507

H-Index - 61

eISSN - 2588-9222

pISSN - 2221-1691

DOI - 10.1016/j.apjtb.2017.05.003

Subject(s) - chronic lymphocytic leukemia , curcumin , medicine , leukemia , cancer , toxicity , oncology , pharmacology

Curcumin is a widely researched natural product and is known to possess anti-carcinogenic properties. Chronic lymphocytic leukemia is a type of leukemia that principally affects patients with age higher than 60 years. Since the toxicity of conventional drugs exceeds the benefits of treating this leukemia type, patients are treated only in the advanced symptomatic stages. The current article reviews curcumin, its general actions and targets in cancer, and specifically that of it in chronic lymphocytic leukemia

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research